| Pfizer Inc. (PFE) | |||
|---|---|---|---|
| 43.8 -0.77 (-1.73%) | 12-14 16:03 | ||
| Open: | 44.08 | Pre. Close: | 44.57 |
| High: | 44.12 | Low: | 43.425 |
| Volume: | 31,333,031 | Market Cap: | 253185M |
| Price Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 44.172 - 44.404 | 44.404 - 44.602 |
| Low: | 42.864 - 43.13 | 43.13 - 43.356 |
| Close: | 43.413 - 43.865 | 43.865 - 44.249 |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 52.44 One year: 54.28 |
| Support: | Support1: 42.35 Support2: 35.24 |
| Resistance: | Resistance1: 44.90 Resistance2: 46.47 |
| Pivot: | 44.55  |
| Moving Averages: | MA(5): 44.20 MA(20): 44.29 MA(100): 42.93 MA(250): 38.93 |
| MACD: | MACD(12,26): 0.15 Signal(12,26,9): 0.25 |
| %K %D: | %K(14,3): 38.28 %D(3): 38.85 |
| RSI: | RSI(14): 47.40 |
| 52-Week: | High: 46.47 Low: 33.2 Change(%): 17.9 |
| Average Vol(K): | 3-Month: 2340350 10-Days: 2624307 |
| Price, MAs and Bollinger Bands |
|---|
| Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.PFE has closed above bottom band by 30.1%. Bollinger Bands are 24.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Stock News |
|---|
|
2018-12-14T12:10:00-05:00 Pfizer Declares First-Quarter 2019 Dividend 2018-12-14T10:29:00-05:00 Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, ZIRABEV(TM) (bevacizumab) 2018-12-14T08:00:00-05:00 Pfizer Initiates Phase 3 Program for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older |
| Financial Analysis | |
|---|---|
| Growth |  |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. | |
| Profitability |  |
| Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs. | |
| Solvency |  |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. | |
| Efficiency | |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. | |
| Stock Basics & Statistics | |
|---|---|
| Sector: Healthcare | |
| Industry: Drug Manufacturers - Major | |
| Shares Out. (M) | 5780.47 |
| Shares Float (M) | 5766.67 |
| % Held by Insiders | |
| % Held by Institutions | 112.70 |
| Shares Short (K) | 47356 |
| Shares Short Prior Month (K) | |
| Stock Financials | |
|---|---|
| EPS | 2.980 |
| EPS Est. Current Year | 2.560 |
| EPS Est. Next Year | 2.760 |
| EPS Est. Next Quarter | 0.560 |
| Forward EPS | 3.059 |
| Book Value (p.s.) | 3.650 |
| PEG Ratio | 2.02 |
| Profit Margin | 44.22 |
| Operating Margin | 28.35 |
| Return on Assets (ttm) | 14.1 |
| Return on Equity (ttm) | 36.3 |
| Qtrly Rev. Growth | |
| Gross Profit (p.s.) | 1.807 |
| Sales Per Share | |
| EBITDA (p.s.) | 0.620 |
| Qtrly Earnings Growth | 44.90 |
| Operating Cash Flow (M) | 17850.00 |
| Levered Free Cash Flow (M) | 15540.00 |
| Stock Valuation | |
|---|---|
| P/E | 14.71 |
| P/E Growth Ratio | -0.02 |
| P/BV | 12.01 |
| P/S | 28099000320.00 |
| P/CF | 14.20 |
| Dividend Yield | 0.07 |
| Dividends & Splits | |
|---|---|
| Dividend | 3.097 |
| Dividend Pay Date | 2018-12-03 |
| Ex-Dividend Date | 2018-11-08 |
| Forward Dividend | 1.360 |
| Last Split Date | |
| Last Split Ratio | -1e+010 |
